IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 3 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,626,000 | -11.2% | 8,797,000 | 0.0% | 0.76% | -50.4% |
| Q2 2018 | $41,232,000 | -20.6% | 8,797,000 | -50.0% | 1.54% | +10.7% |
| Q1 2018 | $51,944,000 | +81.6% | 17,594,000 | +100.0% | 1.39% | +86.3% |
| Q4 2017 | $28,605,000 | +14.8% | 8,797,000 | 0.0% | 0.74% | +42.4% |
| Q3 2017 | $24,910,000 | +94.1% | 8,797,000 | +25.7% | 0.52% | +55.2% |
| Q2 2017 | $12,833,000 | – | 7,000,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Castle Creek Arbitrage, LLC | 5,512,000 | $7,743,000 | 0.74% |
| Orbimed Advisors | 30,000,000 | $42,261,000 | 0.48% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 14,093,000 | $19,819,000 | 0.29% |
| WOLVERINE ASSET MANAGEMENT LLC | 10,010,000 | $14,034,000 | 0.22% |
| CSS LLC/IL | 1,000,000 | $1,408,000 | 0.08% |
| Jefferies Group LLC | 4,165,000 | $5,851,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 13,000,000 | $18,354,000 | 0.04% |
| PALISADE CAPITAL MANAGEMENT, LP | 535,000 | $751,000 | 0.03% |
| Citadel Advisors | 13,990,000 | $19,718,000 | 0.02% |
| AVIVA PLC | 2,000,000 | $2,824,000 | 0.02% |